Surgery comparison for junction cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two surgical techniques for treating a specific type of cancer at the junction of the stomach and esophagus. It aims to find which surgery offers better outcomes for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of cancer called Siewert Type II at the junction of the stomach and esophagus.
- Your blood pressure is under 160/100 mmHg, blood sugar is between 5.6 and 11.2 mmol/L, and your heart, lungs, liver, and kidneys are working well.
- Your tumor is 5 centimeters or smaller on a CT scan, and any suspicious lymph nodes are also small.
- You are in good enough health to be up and about (ECOG score 0 or 1).
- You have not had any previous cancer treatments like chemo, radiation, or immunotherapy for this cancer, and you have no history of other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
This trial compares different surgical approaches for removing Siewert type II cancer at the esophagus–stomach junction. It aims to find which operation works best for people who can have the tumor removed.
This trial compares two types of stomach-removing surgeries (total vs. partial gastrectomy) in people with a certain kind of advanced gastroesophageal junction cancer. The goal is to find out which surgery leads to better outcomes.
This study compares two ways surgeons reconnect the digestive tract after removing the whole stomach for certain stomach cancers near the esophagus. It aims to see which technique is safer and leads to better recovery and outcomes.
This trial compares two treatment approaches for a specific type of cancer at the junction of the esophagus and stomach. One approach combines chemotherapy before and after surgery, while the other adds radiation before surgery. The goal is to see which approach helps patients live longer with fewer side effects.
This study compares two ways to perform surgery for esophageal cancer. The goal is to see if doing the surgery with minimally invasive techniques (using small incisions and cameras) is as safe and effective as a hybrid method that uses both small and larger incisions. Your participation may help doctors improve surgical options for future patients.
Hear when a new Esophagogastric Junction Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.